Insider · CIK 0001815707

Basso Stephen

Reports to the SEC for 2 companies · BURLINGAME, CA

sec.gov

Transactions

Companies

Filings

CIK

0001815707

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-20	INVAInnoviva, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−558 sh	$21.00	−$11.7K	88,013
2026-05-20	INVAInnoviva, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−559 sh	$22.24	−$12.4K	88,571
2026-05-15	INVAInnoviva, Inc.A Award	Chief Financial Officer	AAward	+1,123 sh	—	—	89,130
2026-05-04	INVAInnoviva, Inc.A Award	Chief Financial Officer	AAward	+38K sh	—	—	88,007
2026-05-04	INVAInnoviva, Inc. · Non-statutory Stock OptionA Award	Chief Financial Officer	AAward	+93.8K sh	—	—	93,750
2026-02-20	INVAInnoviva, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,244 sh	$23.39	−$29.1K	50,013
2025-11-20	INVAInnoviva, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−237 sh	$21.16	−$5,014.92	51,257
2025-11-15	INVAInnoviva, Inc.A Award	Chief Financial Officer	AAward	+604 sh	—	—	51,494
2025-11-03	INVAInnoviva, Inc.A Award	Chief Financial Officer	AAward	+27.6K sh	$18.11	+$500K	50,890
2025-08-20	INVAInnoviva, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−237 sh	$19.95	−$4,728.15	23,281
2025-05-20	INVAInnoviva, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−237 sh	$18.78	−$4,450.86	23,518
2025-05-15	INVAInnoviva, Inc.A Award	Chief Financial Officer	AAward	+1,353 sh	—	—	23,755
2025-02-24	INVAInnoviva, Inc. · Non-statutory Stock OptionA Award	Chief Financial Officer	AAward	+101K sh	—	—	276,730
2025-02-24	INVAInnoviva, Inc.A Award	Chief Financial Officer	AAward	+10.6K sh	$18.08	+$191K	22,402
2025-02-20	INVAInnoviva, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,106 sh	$18.07	−$20K	11,833
2024-11-15	INVAInnoviva, Inc.A Award	Chief Financial Officer	AAward	+843 sh	—	—	12,939
2024-03-05	INVAInnoviva, Inc.A Award	Chief Financial Officer	AAward	+12.1K sh	$14.88	+$180K	12,096
2024-03-05	INVAInnoviva, Inc. · Non-statutory Stock OptionA Award	Chief Financial Officer	AAward	+25.9K sh	—	—	175,899
2023-08-31	INVAInnoviva, Inc. · Nonqualified Stock OptionA Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2021-03-24	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	SVP Finance (PFO)	AAward	+13K sh	—	—	13,000
2021-03-04	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	SVP Finance (PFO)	AAward	+27K sh	—	—	27,000
2021-01-13	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	SVP Finance (PFO)	AAward	+41.8K sh	—	—	41,794
2020-07-23	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	SVP Finance (PFO)	AAward	+27.4K sh	—	—	27,433

Recent filings

Accepted (ET)
Aug 244
Basso Stephen0001193125-26-363610
SEC(opens sec.gov)
May 224
Basso Stephen0001193125-26-236913
SEC(opens sec.gov)
May 64
Basso Stephen0001193125-26-209005
SEC(opens sec.gov)
Feb 244
Basso Stephen0001193125-26-067029
SEC(opens sec.gov)
Nov 244
Basso Stephen0001104659-25-115427
SEC(opens sec.gov)
Nov 54
Basso Stephen0001104659-25-107236
SEC(opens sec.gov)
Aug 224
Basso Stephen0001104659-25-081891
SEC(opens sec.gov)
May 224
Basso Stephen0001104659-25-051998
SEC(opens sec.gov)
Mar 264
Basso Stephen0000899140-25-000473
SEC(opens sec.gov)
Feb 244
Basso Stephen0000899140-25-000360
SEC(opens sec.gov)
Mar 74
Basso Stephen0001104659-24-032003
SEC(opens sec.gov)
Aug 314
Basso Stephen0001104659-23-097374
SEC(opens sec.gov)
Mar 254
Basso Stephen0001209191-21-022980
SEC(opens sec.gov)

Companies

Address

1350 OLD BAYSHORE HIGHWAY, SUITE 400

BURLINGAME, CA, 94010